MA10-MA50 Bull Crossover Stocks (Jun. 04)

NASDAQ: AMDA (Amedica Corp)

AMDA (Amedica Corp)  has a YTD performance of -65.00% in the Medical Appliances & Equipment industry.

AMDA has closed at $0.337, its traded Volume was 4039.22K shares, AMDA opened the Day at $0.348, it made an intraday Low of $0.317, and an intraday High of $0.36. AMDA (Amedica Corp) 52-week High is $4.96, 52-week Low is: $0.204, it has supports at $0.2 and $0.16, resistances at $0.41 and $0.55. AMDA’s earning is $-1.9 per share, Next quarter estimated EPS is $-0.03, current year estimated EPS is $-0.24. Its PE ratio is 0. Overall, this stock is rated BUY today.

NASDAQ: DARA (Dara Biosciences)

DARA BioSciences (DARA) announced today that it has signed a merger agreement with Midatech Pharma, with DARA shareholders receiving Midatech Pharma stock upon transaction closing (DARA). Based on the current price of Midatech, each DARA share will be converted into ADRs with a value equivalent to approximately $1.20 per DARA share.

DARA has closed at $0.99, its traded Volume was 4331.56K shares, DARA opened the Day at $1.02, it made an intraday Low of $0.9, and an intraday High of $1.03. DARA (Dara Biosciences) 52-week High is $1.64, 52-week Low is: $0.67, it has supports at $0.8 and $0.67, resistances at $1.02 and $1.19. DARA’s earning is $-0.54 per share, Next quarter estimated EPS is $0, current year estimated EPS is $0. Its PE ratio is -2. Overall, this stock is rated BUY today.

NASDAQ: LTBR (Lightbridge Corp)

Lightbridge Corporation (LTBR) today announced that the Korean Intellectual Property Office has approved and issued to Lightbridge a key patent covering the Company’s multi-lobed metallic fuel rod design and fuel assemblies.

LTBR  has closed at $1.72, its traded Volume was 2606.02K shares, LTBR opened the Day at $1.36, it made an intraday Low of $1.31, and an intraday High of $1.78. LTBR (Lightbridge Corp) 52-week High is $3.54, 52-week Low is: $1.03, it has supports at $1.04 and $0.86, resistances at $2.2 and $2.92. LTBR’s earning is $-0.28 per share, Next quarter estimated EPS is $0, current year estimated EPS is $0. Its PE ratio is -6. Overall, this stock is rated BUY today.

NASDAQ: PPHM (Peregrine Pharmaceuticals Inc)

Peregrine Pharmaceuticals, Inc. (PPHM) today provided a corporate update on its immuno-oncology pipeline, its wholly-owned contract manufacturing business, Avid Bioservices, as well as anticipated upcoming milestones. This update outlines the expansion of the bavituximab clinical pipeline with a focus on exploring expanded indications and combinations in lung and breast cancers.

PPHM has closed at $1.46, its traded Volume was 1080.41K shares, PPHM opened the Day at $1.44, it made an intraday Low of $1.44, and an intraday High of $1.48. PPHM (Peregrine Pharmaceuticals Inc) 52-week High is $1.95, 52-week Low is: $1.19, it has supports at $1.34 and $1.25, resistances at $1.5 and $1.75. PPHM’s earning is $-0.29 per share, Next quarter estimated EPS is $0, current year estimated EPS is $0. Its PE ratio is -5. Overall, this stock is rated BUY today.